Annie Ho

Thomas Jefferson University

Papers

2

Total Citations

5

H-Index

1

About

Annie Ho is a thoracic surgeon and clinical researcher whose work centers on advancing minimally invasive surgical techniques for lung cancer, particularly through robotic-assisted approaches. Her major contributions focus on evaluating the safety and efficacy of robotic lobectomy and wedge resection in patients with non-small cell lung cancer (NSCLC). Notably, her 2024 study on robotic lobectomy after neoadjuvant immunotherapy and chemotherapy—cited 4 times—provides early real-world evidence that these procedures are safe despite increased operative challenges, helping to guide treatment sequencing. Her 2025 work, with 1 citation, investigates whether robotic-assisted surgery improves compliance with guideline-directed lymph node sampling during wedge resection for early-stage NSCLC, a critical factor for ensuring high-quality oncologic outcomes. By addressing gaps in perioperative care and surgical quality, Ho’s research directly impacts clinical decision-making for lung cancer patients. Her findings are particularly valuable for surgeons and oncologists navigating the integration of immunotherapy with advanced surgical platforms, positioning her as a key voice in the evolution of robotic thoracic oncology.

Research Focus

Key Achievements

1
H-Index
2
Papers
5
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Institutional Experience With Robotic Lobectomy After Neoadjuvant Immunotherapy and Chemotherapy
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Thomas Jefferson University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago